Protein levels were determined using ELISAs and performed by Tethys Biosciences, Inc (Emeryville, CA), as previously reported 1 . Normal Human Serum from VWR (Radnor, PA), a pool made from 10-16% of Tromsø study samples, and dilution buffer were used as controls.
Power Calculations
Our power to detect causal variants of varying effect sizes was determined using an equation from the Abecasis laboratory (http://genome.sph.umich.edu/wiki/Power_Calculations:_Quantitative_Traits) for common variants and the SKAT R package 7 for rare variants. Power for the common variant analyses was calculated using a sample size of 300 individuals, a phenotypic variance (R 2 ) from 0.0 to 1.0, and alpha levels of 6.97 x 10 -7 for the cis association, 7.29 x 10 -5 for the cis-acting-in-trans analysis, and 1.25 x 10 -8 for the trans analysis (Supplemental Table 4 , Supplemental Figure 1 ). Power for the rare variant analysis was calculated using a sample size of 300 individuals, an effect size (β in standard deviations) from 0.0 to 5.0, the default haplotypes (European) for the SKAT package, a causal MAF cutoff of 5%, a sampling subregion length of 3kb, and alpha levels of 3.72 x 10 -4
for the cis association, 5.30 x 10 -5 for the cis-acting-in-trans, and 9.21 x 10 -6 for the trans associations (Supplemental Table 4 , Supplemental Figure 2 ). AGT sun-exposed skin, transformed fibroblasts, non-exposed skin, subcutaneous adipose, lung, colon, breast, testis, esophagus (2.0x10-6 to 1.3x10-33); RP11-99J16_A.2 transformed fibroblasts, sun-exposed skin, subcutaneous adipose (6.0x10-10 to 1.0x10-14)
in LD with rs699 and rs5051 (r 2 = 0.24, D' = 1) which are associated with hypertension, lower promoter activity and transcription amount Bolded indicates a nominal P-value of <0.05. β, effect size. SE, standard error * rs8077638 was not present in the INVENT dataset, so the next most significant variant (rs8065251) was looked up in both studies as well. † The top variant for C3 (rs11569415) was not present in either CARDIoGRAM or INVENT so the next most significant variant (rs2230199) was used. ‡ The association with VTE was no longer significant after adjustment that included rs4253417. No significant variants for LP(a) or MMP8 were present in either study.
